Impact of Interleukin-17 Inhibitor Therapy on Arterial Intima-media Thickness among Severe Psoriatic Patients
Background: Psoriasis is frequently accompanied by cardiovascular diseases based on the shared immunopathogenic pathway. Authors determined the effect of interleukin (IL)-17 inhibitor therapy on arterial intima-media thickness (IMT) among severe psoriatic patients. Methods: Thirty-one severe psoriat...
Main Authors: | Éva Anna Piros, Ákos Szabó, Fanni Rencz, Valentin Brodszky, Klára Szalai, Noémi Galajda, Bálint Szilveszter, Edit Dósa, Béla Merkely, Péter Holló |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/9/919 |
Similar Items
-
Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters
by: Éva Anna Piros, et al.
Published: (2021-06-01) -
Studying the relevance of psoriasis with increased artery intima–media thickness, in patients of skin disease clinics of kashan medical science university in 2016
by: Rezan Talaee, et al.
Published: (2020-01-01) -
The Association of Psoriatic Arthritis with Carotid Intima-Media Thickness
by: Hamidreza Talari, et al.
Published: (2021-03-01) -
Could SCUBE-1 be a marker for subclinical atherosclerosis other than carotid artery intima-media thickness in patients with psoriasis?
by: Havva Hilal Ayvaz Çelik, et al.
Published: (2023-08-01) -
Frequency of Subclinical Atherosclerosis in Patients of Psoriasis
by: Sobia Awan, et al.
Published: (2022-11-01)